Matt Posard
Matt Posard - currently Senior Vice President and General Manager of Translational & Consumer Genomics at Illumina - has been appointed onto the Board of Directors at Halozyme Therapeutics.
Halozyme’s President and CEO, Dr. Gregory Frost, said: “We welcome Matt to our Board of Directors. His strategic marketing experience will complement Halozyme's Board well as we increase our commercial activities with Hylenex.”